Biolife Sciences Stock Alpha and Beta Analysis

BLFE Stock  USD 0.0001  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BioLife Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in BioLife Sciences over a specified time horizon. Remember, high BioLife Sciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BioLife Sciences' market risk premium analysis include:
Beta
0.0
Alpha
0.0
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although BioLife Sciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, BioLife Sciences did 0.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of BioLife Sciences stock's relative risk over its benchmark. BioLife Sciences has a beta of 0.00  . The returns on DOW JONES INDUSTRIAL and BioLife Sciences are completely uncorrelated. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out BioLife Sciences Backtesting, BioLife Sciences Valuation, BioLife Sciences Correlation, BioLife Sciences Hype Analysis, BioLife Sciences Volatility, BioLife Sciences History and analyze BioLife Sciences Performance.

BioLife Sciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BioLife Sciences market risk premium is the additional return an investor will receive from holding BioLife Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioLife Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BioLife Sciences' performance over market.
α0.00   β0.00

BioLife Sciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of BioLife Sciences' Buy-and-hold return. Our buy-and-hold chart shows how BioLife Sciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

BioLife Sciences Market Price Analysis

Market price analysis indicators help investors to evaluate how BioLife Sciences pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioLife Sciences shares will generate the highest return on investment. By understating and applying BioLife Sciences pink sheet market price indicators, traders can identify BioLife Sciences position entry and exit signals to maximize returns.

BioLife Sciences Return and Market Media

 Price Growth (%)  
       Timeline  

About BioLife Sciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BioLife or other pink sheets. Alpha measures the amount that position in BioLife Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioLife Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioLife Sciences' short interest history, or implied volatility extrapolated from BioLife Sciences options trading.

Build Portfolio with BioLife Sciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Other Information on Investing in BioLife Pink Sheet

BioLife Sciences financial ratios help investors to determine whether BioLife Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLife with respect to the benefits of owning BioLife Sciences security.